The study elucidates the structural interaction between BK channel alpha and beta subunits that confers resistance to charybdotoxin, which may inform future channel inhibitor design.
Hypothesis-generating for BK channel pharmacology; leaves open selective inhibitor design pending mammalian validation.
The functional diversity of large conductance Ca(2+)- and voltage-dependent K(+) (BK) channels arises mainly from co-assembly of the pore-forming mSlo alpha subunits with four tissue-enriched auxiliary beta subunits. The structural basis of the interaction between alpha subunits with beta subunits is not well understood. Using computational and experimental methods, we demonstrated that four mSlo turrets decentralized distally from the channel pore to provide a wide open conformation and that the mSlo and hbeta4 subunits together formed a "helmet" containing three basic residues (Lys-120, Arg-121, and Lys-125), which impeded the entry of charybdotoxin (ChTX) by both the electrostatic interaction and limited space. In addition, the tyrosine insert mutant (in100Y) showed 56% inhibition, with a K(d) = 17 nm, suggesting that the hbeta4 lacks an external ChTX-binding site (Tyr-100). We also found that mSlo had an internal binding site (Tyr-294) in the alpha subunits that could "permanently" block 15% of mSlo+hbeta4 currents in the presence of 100 nm ChTX. These findings provide a better understanding of the diverse interactions between alpha and beta subunits and will improve the design of channel inhibitors.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2008) studied this question. Charybdotoxin (ChTX) was evaluated on Inhibition of mSlo+hbeta4 currents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: